Vanberra Signal
Free trial

AI for ALS

Curated by Signal

Provider of in silico drug discovery and drug repurposing for age-related diseases

Health Technologyals.ai

Overview

Insilico Medicine is a bioinformatics company utilizes advances in genomics, big data analysis, and deep learning for in silico drug discovery and drug repurposing for age-related diseases. The company pursues internal drug discovery programs in cancer, Parkinson's disease, Alzheimer's disease, Sarcopenia, and Geroprotector discovery. It uses specialized tools such as iPANDA (for signaling pathway activation analysis), PharmaAI (drug discovery engine) and DeepPharma (the predictor of phase I/II clinical trials). It is also working with its collaborators to investigate ALS disease and its new treatments.

Key facts

Founded
2017
Headquarters
Baltimore, United States
Stage
Sign up to view
Industry
Health Technology

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • Khronic

    AI-based insight tools for cannabis strain detection

    Health TechnologyFort Lauderdale, United States

  • ClubReady

    Cloud-based fitness and gym management platform

    Health TechnologySt. Louis, United States

About AI for ALS

What does AI for ALS do?

Insilico Medicine is a bioinformatics company utilizes advances in genomics, big data analysis, and deep learning for in silico drug discovery and drug repurposing for age-related diseases.

Where is AI for ALS headquartered?

AI for ALS is headquartered in Baltimore, United States.

When was AI for ALS founded?

AI for ALS was founded in 2017.

Which sector is AI for ALS in?

AI for ALS operates in Health Technology.

Who are AI for ALS's competitors?

Companies similar to AI for ALS include Khronic, Global Health Enterprises, and ClubReady.